Friyana K. Bhabha

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Case of Primary Cutaneous BRAFV600E+ Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNA.

A Case of Primary Cutaneous BRAFV600E+ Langerhans Cell Histiocytosis, With Underlying Chronic Myelomonocytic Leukaemia, Responsive to Dabrafenib With Subsequent Undetectable Circulating Cell Free DNA.

Journal: The Australasian journal of dermatology

Published: February 09, 2026

Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options.

Journal: Leukemia & lymphoma

Published: December 25, 2025

Radiotherapy dose-response of mycosis fungoides with large cell transformation.

Radiotherapy dose-response of mycosis fungoides with large cell transformation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 29, 2025

Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome.

Immune pathways, current and potential therapies in Mycosis fungoides and Sezary syndrome.

Journal: Expert review of clinical immunology

Published: July 14, 2025

Langerhans cell histiocytosis presenting in the skin in adults: Clinical patterns and outcomes with skin-directed therapy.

Langerhans cell histiocytosis presenting in the skin in adults: Clinical patterns and outcomes with skin-directed therapy.

Journal: Journal of the American Academy of Dermatology

Published: April 10, 2025

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.

Journal: British journal of haematology

Published: February 10, 2025

Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.

Complete skin remission of Sneddon-Wilkinson disease with acalabrutinib.

Journal: The Australasian journal of dermatology

Published: January 11, 2024

CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.

CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.

Journal: The Australasian journal of dermatology

Published: July 31, 2022

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder.

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 15, 2022

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.

Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.

Journal: The Australasian journal of dermatology

Published: June 16, 2020

Immunoglobulin Type Gamma 4-Related Disease Presenting with Cutaneous Plaques.

Immunoglobulin Type Gamma 4-Related Disease Presenting with Cutaneous Plaques.

Journal: The Australasian journal of dermatology

Published: January 29, 2016

Terminal osseous dysplasia with pigmentary defects; Case and brief review of filamin A-related disorders.

Terminal osseous dysplasia with pigmentary defects; Case and brief review of filamin A-related disorders.

Journal: The Australasian journal of dermatology

Published: June 11, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026